Dreman Value Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$1.89M Sell
13,572
-702
-5% -$103K 0.86% 17
2017
Q4
$1.96M Buy
14,274
+8,499
+147% +$1.12M 1.1% 18
2017
Q3
$749K Hold
5,775
0.41% 81
2017
Q2
$765K Buy
5,775
+2,652
+85% +$325K 0.42% 80
2017
Q1
$385K Hold
3,123
0.22% 199
2016
Q4
$344K Hold
3,123
0.19% 216
2016
Q3
$369K Hold
3,123
0.22% 114
2016
Q2
$350K Sell
3,123
-566
-15% -$60.9K 0.22% 118
2016
Q1
$371K Buy
3,689
+3,123
+552% +$299K 0.04% 225
2015
Q4
$60K Hold
566
0.02% 146
2015
Q3
$53K Sell
566
-6,390
-92% -$661K 0.01% 371
2015
Q2
$724K Buy
+6,956
New +$724K 0.06% 225
2014
Q2
Sell
-836
Closed -$71K 499
2014
Q1
$71K Buy
+836
New +$66.7K 0.01% 329

Other funds holding LH

Dreman Value Management's LH Position: Q1 2018 in Review

Dreman Value Management reduced its Labcorp (LH) stake by 4.9% in Q1 2018, selling an estimated $103K and leaving 13,572 shares worth $1.89M. The position accounts for 0.86% of the portfolio, ranked #17.

Dreman Value Management first reported a position in LH in Q1 2014 and has held it in 13 quarters since. The position peaked at $1.96M in Q4 2017. 791 funds tracked by Wall St. Rank hold LH as of Q1 2018.

  • Dreman Value Management held 13,572 shares of Labcorp worth $1.89M as of Q1 2018.
  • Dreman Value Management sold 702 Labcorp shares in Q1 2018, an estimated $103K.
  • Labcorp made up 0.86% of Dreman Value Management's portfolio in Q1 2018, its #17 holding.
  • Dreman Value Management first reported a position in Labcorp in Q1 2014 and has held it in 13 quarters since.
  • Dreman Value Management's Labcorp position peaked at $1.96M in Q4 2017.
  • 791 funds tracked by Wall St. Rank held Labcorp as of Q1 2018.

Based on Dreman Value Management's 13F filing for Q1 2018, filed 2 May 2018.